Jefferies Raises PT on Alexion Pharmaceuticals To $87

April 25, 2011 6:58 AM | 8 seconds read |
Jefferies & Company has raised the price target on Alexion Pharmaceuticals ALXN from $77 to $87 and maintains its Hold rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetAnalyst RatingsAlexion PharmaceuticalsBiotechnologyHealth CareJefferies & Company
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved